Basit öğe kaydını göster

Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)

dc.contributor.authorVeccia, Alessandro
dc.contributor.authorRoussel, Eduard
dc.contributor.authorAlbersen, Maarten
dc.contributor.authorPavan, Nicola
dc.contributor.authorClaps, Francesco
dc.contributor.authorAntonelli, Alessandro
dc.contributor.authorPalumbo, Carlotta
dc.contributor.authorMarchioni, Michele
dc.contributor.authorKriegmair, Maximilian
dc.contributor.authorHeck, Mathias
dc.contributor.authorAmiel, Thomas
dc.contributor.authorPorpiglia, Francesco
dc.contributor.authorCeccucci, Enrico
dc.contributor.authorCampi, Riccardo
dc.contributor.authorMinervini, Andrea
dc.contributor.authorVan Bruwaene, Siska
dc.contributor.authorLinares, Estefania
dc.contributor.authorHevia, Vital
dc.contributor.authorMusquera, Mireia
dc.contributor.authorDerweesh, Ithaar
dc.contributor.authorKlatte, Tobias
dc.contributor.authorErdem, Selçuk
dc.contributor.authorCarmen Mir, Maria
dc.contributor.authorBradshaw, Aaron
dc.contributor.authorAutorino, Riccardo
dc.contributor.authorGuruli, Georgi
dc.date.accessioned2021-03-02T16:05:32Z
dc.date.available2021-03-02T16:05:32Z
dc.identifier.citationMarchioni M., Kriegmair M., Heck M., Amiel T., Porpiglia F., Ceccucci E., Campi R., Minervini A., Van Bruwaene S., Linares E., et al., "Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)", European Urology, cilt.01016202012010, 2020
dc.identifier.issn0302-2838
dc.identifier.othervv_1032021
dc.identifier.otherav_39a00fa0-3c94-4d17-ae66-671740128304
dc.identifier.urihttp://hdl.handle.net/20.500.12627/2262
dc.identifier.urihttps://euoncology.europeanurology.com/article/S2588-9311(20)30218-2/fulltext
dc.identifier.urihttps://doi.org/10.1016/j.euo.2020.12.010
dc.language.isoeng
dc.subjectAssessment and Diagnosis
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectCERRAHİ
dc.subjectTIP, GENEL & İÇECEK
dc.subjectONKOLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectÜroloji
dc.subjectNephrology
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectSurgery
dc.subjectOncology
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectUrology
dc.subjectInternal Medicine
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.titleDevelopment of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
dc.typeMakale
dc.relation.journalEuropean Urology
dc.contributor.departmentUniversity of California, San Diego , UC San Diego Moores Cancer Center ,
dc.identifier.volume01016202012010
dc.contributor.firstauthorID2488882


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster